Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Capital Research Global Investors | 19.30M | $309.0M | 1.21% | +193.5K | 2026-06-30 |
| FMR LLC | 9.60M | $153.0M | 0.60% | +2.48M | 2026-06-30 |
| MORGAN STANLEY | 6.99M | $112.0M | 0.44% | +525.3K | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.05M | $96.0M | 0.38% | -374.2K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 5.13M | $82.0M | 0.32% | -493.7K | 2026-06-30 |
| BRANDES INVESTMENT PARTNERS, LP | 4.54M | $72.0M | 0.29% | +108.7K | 2026-06-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.73M | $59.0M | 0.23% | +616.6K | 2026-06-30 |
| BlackRock, Inc. | 3.69M | $59.0M | 0.23% | +511.7K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 2.57M | $41.0M | 0.16% | -421.1K | 2026-06-30 |
| Qube Research & Technologies Ltd | 2.21M | $35.0M | 0.14% | +2.01M | 2026-06-30 |
